CalciMedica Inc expected to post a loss of 50 cents a share - Earnings Preview

Calcimedica

06/11/2024 14:28

* CalciMedica Inc  CALC.OQ   CALC.O  is expected to show no
change
in quarterly revenue when it reports  results on November 7
(estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for CalciMedica Inc is for a
loss
of 50 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CalciMedica
Inc
is $16.00​, above​ its last closing price of $3.54. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.52       -0.53      -0.36     Beat    31.6
 Mar. 31 2024  -0.69       -0.67      0.01      Beat    101.5
 Dec. 31 2023  -0.72       -0.87      -0.23     Beat    73.6​
 Sep. 30 2023  -1.14       -1.14      -0.82     Beat    28.1
 ​​Jun.        -1.05       -1.04      -1.11     Missed  -6.2
 30 2023                                                
 Jan. 1 0001   -0.73       -0.73      -23.43    Missed  -3,109
                                                        .6​
 Sep. 30 2022              -6.16      -6.44     Missed  -4.5
 This summary was machine generated November 6 at 14:27 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)